{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:55:08Z","timestamp":1793663708051,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arth.2025.06.032","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:25:17Z","timestamp":1749669917000},"page":"225-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Aspirin Versus Other Anticoagulants for the Initial Prevention of Venous Thromboembolism Following Elective Total Hip and Knee Arthroplasty: An Umbrella Review and Meta-Analysis"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-2490","authenticated-orcid":false,"given":"Roham","family":"Borazjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Khorram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Nerys-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir R.","family":"Kachooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7374-0814","authenticated-orcid":false,"given":"Ali","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.06.032_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.06.032_bib3","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of vte in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.06.032_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-021-02274-z","article-title":"Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis","volume":"16","author":"Hu","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.arth.2025.06.032_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/BLO.0b013e31805b7681","article-title":"Three decades of clinical, basic, and applied research on thromboembolic disease after THA: Rationale and clinical results of a multimodal prophylaxis protocol","volume":"459","author":"Salvati","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.06.032_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/JBJS.16.01253","article-title":"Venous thromboembolism following hip and knee arthroplasty: the role of aspirin","volume":"99","author":"Parvizi","year":"2017","journal-title":"JBJS"},{"key":"10.1016\/j.arth.2025.06.032_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1182\/blood-2018-99-118635","article-title":"Aspirin use in venous thromboembolism prophylaxis following hip or knee arthroplasty: a network meta-analysis of randomized controlled trials","volume":"132","author":"Haykal","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.arth.2025.06.032_bib8","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2106\/JBJS.L.01328","article-title":"Prevention of venous thromboembolic disease after total hip and knee arthroplasty","volume":"95","author":"Lieberman","year":"2013","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.arth.2025.06.032_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arth.2011.03.032","article-title":"A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty","volume":"27","year":"2012","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib10","first-page":"6245","article-title":"Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis","volume":"25","author":"Cai","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.arth.2025.06.032_bib11","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after tka: aspirin, warfarin, enoxaparin, or factor xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.06.032_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/pds.4737","article-title":"Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: a nationwide study in korea","volume":"28","author":"Kim","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.arth.2025.06.032_bib13","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.arth.2020.04.088","article-title":"Is aspirin as effective as the newer direct oral anticoagulants for venous thromboembolism prophylaxis after total hip and knee arthroplasty? An analysis from the national joint registry for england, wales, northern Ireland, and the Isle of Man","volume":"35","author":"Matharu","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jor.2019.05.008","article-title":"Should we use dabigatran or aspirin thromboprophylaxis in total hip and knee arthroplasty? A natural experiment","volume":"16","author":"McHale","year":"2019","journal-title":"J Orthopaedics"},{"key":"10.1016\/j.arth.2025.06.032_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.knee.2019.01.004","article-title":"Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty","volume":"26","author":"Richardson","year":"2019","journal-title":"Knee"},{"key":"10.1016\/j.arth.2025.06.032_bib16","first-page":"132","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"JBI Evid Implement"},{"key":"10.1016\/j.arth.2025.06.032_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.arth.2025.06.032_bib18","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2025.06.032_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/ans.15122","article-title":"Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review","volume":"89","author":"Nadi","year":"2019","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.arth.2025.06.032_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250096","article-title":"Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: a prisma-compliant bayesian network meta-analysis","volume":"16","author":"He","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.arth.2025.06.032_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1055\/s-0039-1693460","article-title":"Rivaroxaban versus aspirin in prevention of venous thromboembolism: a meta-analysis of 9 randomized controlled trials comprising 7,656 patients","volume":"119","author":"Xie","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arth.2025.06.032_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1530\/EOR-22-0053","article-title":"Clinical effectiveness and safety of aspirin and other anticoagulants for venous thromboembolism prophylaxis after major orthopedic surgery: a systematic review and meta-analysis of randomized clinical trials","volume":"7","author":"Singjie","year":"2022","journal-title":"EFFORT Open Rev"},{"key":"10.1016\/j.arth.2025.06.032_bib23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1302\/0301-620X.98B8.36957","article-title":"Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty","volume":"98","author":"Wilson","year":"2016","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2025.06.032_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2106\/00004623-200007000-00004","article-title":"A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty","volume":"82","author":"Freedman","year":"2000","journal-title":"J Bone Jt Surg Ser A"},{"key":"10.1016\/j.arth.2025.06.032_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1054\/arth.2001.21499","article-title":"A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty","volume":"16","author":"Brookenthal","year":"2001","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jhm.2224","article-title":"Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis","volume":"9","author":"Drescher","year":"2014","journal-title":"J Hosp Med"},{"key":"10.1016\/j.arth.2025.06.032_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.thromres.2014.06.027","article-title":"A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty","volume":"134","author":"Lussana","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2025.06.032_bib28","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023055","article-title":"Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: a protocol for meta-analysis","volume":"99","author":"Le","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.arth.2025.06.032_bib30","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1302\/2058-5241.6.200120","article-title":"Prevention of venous thromboembolism with aspirin following knee surgery: a systematic review and meta-analysis","volume":"6","author":"Marrannes","year":"2021","journal-title":"EFFORT Open Rev"},{"key":"10.1016\/j.arth.2025.06.032_bib31","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1007\/s00167-023-07500-1","article-title":"Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"P","year":"2023","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.arth.2025.06.032_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/med-2023-0760","article-title":"Aspirin versus lmwh for vte prophylaxis after orthopedic surgery","volume":"18","author":"Wei","year":"2023","journal-title":"Open Med"},{"key":"10.1016\/j.arth.2025.06.032_bib33","first-page":"e191","article-title":"A systematic review on the use of aspirin in the prevention of deep vein thrombosis in major elective lower limb orthopedic surgery: an update from the past 3 years","volume":"3","author":"Mistry","year":"2017","journal-title":"Surg J (New York, NY)"},{"key":"10.1016\/j.arth.2025.06.032_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2106\/JBJS.RVW.20.00021","article-title":"Comparison of surgical site infection risk between warfarin, lmwh, and aspirin for venous thromboprophylaxis in tka or tha: a systematic review and meta-analysis","volume":"8","author":"Hughes","year":"2020","journal-title":"JBJS Rev"},{"key":"10.1016\/j.arth.2025.06.032_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otsr.2020.04.002","article-title":"Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: a systematic review and meta-analysis","volume":"107","author":"Farey","year":"2021","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.arth.2025.06.032_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0735-1097(19)32539-2","article-title":"A meta-analysis comparing aspirin versus rivaroxaban for venous thromboembolism prophylaxis in patients with knee or hip arthroplasty","volume":"73","author":"Kohli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arth.2025.06.032_bib37","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American society of hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.arth.2025.06.032_bib38","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.arth.2025.06.032_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14749-y","article-title":"Pharmacological thromboprophylaxis as a risk factor for early periprosthetic joint infection following primary total joint arthroplasty","volume":"12","author":"Pai","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.arth.2025.06.032_bib40","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.arth.2020.07.004","article-title":"Persistent wound drainage among total joint arthroplasty patients receiving aspirin vs coumadin","volume":"35","author":"Singh","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib41","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1016\/j.arth.2023.02.041","article-title":"Aspirin thromboprophylaxis following primary total knee arthroplasty is associated with a lower rate of early prosthetic joint infection compared with other agents","volume":"38","author":"Anil","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11999-007-0092-4","article-title":"Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty","volume":"466","author":"Sharrock","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.06.032_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11999-013-3358-z","article-title":"Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors","volume":"472","author":"Parvizi","year":"2014","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.06.032_bib44","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.arth.2024.10.090","article-title":"Is aspirin an effective prophylaxis against venous thromboembolism in patients undergoing routine total knee or total hip arthroplasty?","volume":"40","author":"Parsa","year":"2025","journal-title":"The J Arthroplasty"},{"key":"10.1016\/j.arth.2025.06.032_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.arth.2025.06.032_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jrsm.1390","article-title":"Examining overlap of included studies in meta-reviews: guidance for using the corrected covered area index","volume":"11","author":"Hennessy","year":"2020","journal-title":"Res Synth Methods"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325007120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325007120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:44:01Z","timestamp":1765251841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325007120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0883540325007120"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.06.032","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Versus Other Anticoagulants for the Initial Prevention of Venous Thromboembolism Following Elective Total Hip and Knee Arthroplasty: An Umbrella Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}